Autism: an emerging ‘neuroimmune disorder’ in search of therapy
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Autism spectrum disorders (ASDs) are neurodevelopmental disorders characterized by difficulties in communication and by repetitive and stereotypic behaviors, as well as by social impairment, attention, cognitive, and learning defects. ASDs present in early childhood and their prevalence has increased significantly to 1/150 children. Despite a number of theories, the actual reasons for this increase are still not clear. There is no reliable screening test, and no definite pathogenesis or curative therapy. Consequently, there is a major gap hampering development of effective treatments. OBJECTIVE: To review recent publications on ASDs pathogenesis and treatment with emphasis on neuroimmune processes and new therapeutic approaches. METHODS: Mostly original papers (450) on epidemiology, possible pathogenesis or treatment of ASDs in Medline from 1990 to May 2009 were reviewed. All authors contributed to this review. RESULTS/CONCLUSION: Increased oxidative stress and immune dysregulation are present in ASDs. Mast-cell activation may contribute to gut-blood-brain barrier disruption and brain inflammation. No effective treatments have emerged. Well-designed clinical trials with nonpsychotropic drugs were few and ASD characteristics varied considerably, making conclusions difficult. Psychotropic drugs are often used for stereotypic and aggressive behaviors. Unique combinations with antioxidant and anti-inflammatory flavonoids hold promise. New potential translational research areas and possible treatments are suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 7×
“Moreover, TNF-receptor II was elevated in 35 children with Increased circulating IL-6 levels that cross the placenta at midgestation and induce the release of fetal stress hormones resulting in fetal brain injury and autistic-like behavior after maternal mouse viral infection [62] Increased IL-6 in the placenta and br…”
BackgroundInfluentialIdentification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“(2009) 10(13) 1/150 [9]; however, the same study could not point to a true increase in incidence.”
BackgroundMaternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 2×
“Risperidone Dopamine receptor antagonist Aggression ↓ Irritability ↓ Weight ↑ [183-185]”
BackgroundAnxiety in children and adolescents with autism spectrum disorders
White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.003 · Cited by 1,427 · cited 1×
“5 Stress, the blood–brain barrier, mast cells, and brain inflammation Anxiety is one of the most common presenting problems for at least a subgroup of children with ASDs, who may also be more prone to stress [140].”
BackgroundAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421 · cited 1×
“However, no gene abnormality alone can explain the apparent increase in prevalence over the last 20 years [28-30].”
BackgroundCytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365 · cited 1×
“TNF and other cytokines can affect cognitive functions in humans [53].”
BackgroundPrevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248 · cited 2×
“Prevalence estimates indicate that ASDs have increased considerably from 4/10,000 before 1980 to as many as 90/10,000 [2-8].”
BackgroundThe Epidemiology of Autism Spectrum Disorders
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., Mandell, D. S., Miller, L. A., Pinto-Martin, J., Reaven, J., et al. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144007 · Cited by 1,228 · cited 2×
“Prevalence estimates indicate that ASDs have increased considerably from 4/10,000 before 1980 to as many as 90/10,000 [2-8].”
BackgroundCommon genetic variants on 5p14.1 associate with autism spectrum disorders
Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M. A., et al. (2009) · Nature · doi:10.1038/nature07999 · Cited by 989 · cited 1×
“However, no gene abnormality alone can explain the apparent increase in prevalence over the last 20 years [28-30].”
BackgroundEvidence-Based Comprehensive Treatments for Early Autism
Rogers, S. J., & Vismara, L. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701817808 · Cited by 984
Elevated immune response in the brain of autistic patients
Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., & Malik, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.002 · Cited by 786
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
The immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 1×
“2 Immune dysregulation in autistic spectrum disorders Increasing evidence suggests that there are some generalized immune abnormalities in at least a subgroup of patients with ASDs (Table 2) [44-47].”
BackgroundThe Rise in Autism and the Role of Age at Diagnosis
Hertz-Picciotto, I., & Delwiche, L. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181902d15 · Cited by 522 · cited 1×
“2-fold increase at best, leaving the majority of ASD cases unexplained [10].”
Background(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482 · cited 1×
“1 Notes in press In spite of the fact that antidepressants are increasingly prescribed to children with ASDs as discussed earlier (Section 2), a recent, multicenter, randomized study of 150 children and adolescents using the selective serotonin re-uptake inhibitor (SSRI) citalopram or placebo for 12 weeks, reported no…”
BackgroundIncreased mast cells in the irritable bowel syndrome
O’Sullivan, Clayton, Breslin, Harman, Bountra, Mclaren, & O’Morain (2000) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2000.00221.x · Cited by 480 · cited 1×
“Mast cells are involved in food-related and other gastrointestinal (GI) pathology [81], such as in inflammatory bowel disease [82], and irritable bowel syndrome [82,83], in which they can increase intestinal permeability, which might also explain other GI complaints in ASD patients [6,84].”
BackgroundChauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.038 · Cited by 424
Gurney, J. G., McPheeters, M. L., & Davis, M. M. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.8.825 · Cited by 411 · cited 3×
“Prevalence estimates indicate that ASDs have increased considerably from 4/10,000 before 1980 to as many as 90/10,000 [2-8].”
BackgroundFombonne, E., Zakarian, R., Bennett, A., Meng, L., & McLean-Heywood, D. (2006) · Pediatrics · doi:10.1542/peds.2005-2993 · Cited by 399 · cited 2×
“ASDs are characterized by varying degrees of dysfunctional communication and social abilities, repetitive and stereotypic behaviors, and by defects in attention, cognition, learning and sensory functioning [1,3].”
BackgroundImmune transcriptome alterations in the temporal cortex of subjects with autism
Garbett, K., Ebert, P. J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K., & Persico, A. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.012 · Cited by 375 · cited 1×
“Recent reviews that have summarized the current findings in autism research focus mostly on neural processes [20,21] or genetics [22-26].”
BackgroundLevels of anxiety and sources of stress in adults with autism
Gillott, A., & Standen, P. J. (2007) · Journal of Intellectual Disabilities · doi:10.1177/1744629507083585 · Cited by 359 · cited 1×
“A comparison of 34 adults with autism and 20 controls – matched for age, gender and intellectual ability – showed that patients were three times as anxious as controls and were significantly less likely to cope with stressful triggers [141].”
BackgroundHow environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325 · cited 1×
“This evidence implies that autistic patients might have excessive reactive oxygen species (ROS) production and reduced methylation capacity [43].”
BackgroundElevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children
Chez, M. G., Dowling, T., Patel, P. B., Khanna, P., & Kominsky, M. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.01.012 · Cited by 317 · cited 1×
“Cerebrospinal fluid (CSF) levels of tumor necrosis factor (TNF) were significantly higher than corresponding serum levels in ten autistic children [50] .”
BackgroundCerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Ashwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R. L., Croen, L. A., Ozonoff, S., Pessah, I. N., & de Water, J. V. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.006 · Cited by 271
Enstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257 · cited 2×
“Serum levels of IgG4, associated with atopic phenotype, were increased in children with autism disorder [49]”
BackgroundWright, R. J., Finn, P., Contreras, J. P., Cohen, S., Wright, R. O., Staudenmayer, J., Wand, M., Perkins, D., Weiss, S. T., & Gold, D. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.032 · Cited by 256 · cited 1×
“Moreover, stress of caregivers during 6- to 18-month-old children was significantly associated with higher serum IgE and TNF, as well as with a predisposition to atopic symptomatology in these children [164] .”
BackgroundEsposito, P., Chandler, N., Kandere, K., Basu, S., Jacobson, S., Connolly, R., Tutor, D., & Theoharides, T. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038497 · Cited by 252
Self-citationGastrointestinal symptoms in a sample of children with pervasive developmental disorders
Nikolov, R. N., Bearss, K. E., Lettinga, J., Erickson, C., Rodowski, M., Aman, M. G., McCracken, J. T., McDougle, C. J., Tierney, E., Vitiello, B., et al. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0637-8 · Cited by 240
Theoharides, T. C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J. J., Webster, E., & Chrousos, G. P. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588332 · Cited by 214
Self-citationSharma, V., Mishra, M., Ghosh, S., Tewari, R., Basu, A., Seth, P., & Sen, E. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.01.016 · Cited by 202
Jyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005) · Neuropsychobiology · doi:10.1159/000084164 · Cited by 201 · cited 2×
“Peripheral blood mononuclear cells from ASD children with GI symptoms produced higher TNF-α in response to gluten gliadin, cow-milk protein, and soy [87].”
BackgroundVojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00180-7 · Cited by 197
Medication use among children with autism spectrum disorders
Oswald, D. P., & Sonenklar, N. A. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.17303 · Cited by 195
Maternal antibrain antibodies in autism
Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L.-C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.005 · Cited by 190 · cited 1×
“(2009) 10(13) adult rat brain proteins were present in mothers of ASD children for 2 – 18 years after the birth of the affected children [72].”
BackgroundGene expression changes in children with autism
Gregg, J. P., Lit, L., Baron, C. A., Hertz-Picciotto, I., Walker, W., Davis, R. A., Croen, L. A., Ozonoff, S., Hansen, R., Pessah, I. N., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2007.09.003 · Cited by 181 · cited 1×
“02) [48] .”
Is autism an autoimmune disease?
Ashwood, P., & Van de Water, J. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.07.036 · Cited by 181
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Lintas, C., & Persico, A. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060871 · Cited by 178
Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D. G., & Van de Water, J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.007 · Cited by 163 · cited 1×
“001) [68] .”
Brain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Antibodies against fetal brain in sera of mothers with autistic children
Singer, H. S., Morris, C. M., Gause, C. D., Gillin, P. K., Crawford, S., & Zimmerman, A. W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.004 · Cited by 152
Antibrain antibodies in children with autism and their unaffected siblings
Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.025 · Cited by 132 · cited 2×
“01) had serum autoantibodies to human brain, especially the cerebellum and cingulate gyrus [69].”
BackgroundLevy, S. E., Souders, M. C., Ittenbach, R. F., Giarelli, E., Mulberg, A. E., & Pinto-Martin, J. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.013 · Cited by 130
Macrophage migration inhibitory factor and autism spectrum disorders
Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., Mulder, E. J., de Bildt, A., Minderaa, R. B., Volkmar, F. R., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3604 · Cited by 118
Jansen, L. M., Gispen-de Wied, C. C., van der Gaag, R.-J., & van Engeland, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300046 · Cited by 118 · cited 1×
“Autistic patients might also have increased activity of the hypothalamic–pituitary–adrenal (HPA), as indicated by elevated salivary cortisol response in children [142], and higher plasma levels of adrenocorticotropin hormone (ACTH) in adults with Asperger’s syndrome [143].”
BackgroundThe Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?
Swartz, H. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0508e15 · Cited by 107
Mast cells and nerves tickle in the tummy
Rijnierse, A., Nijkamp, F. P., & Kraneveld, A. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.008 · Cited by 105
Brain cytokines and neuropsychiatric disorders
Theoharides, T. C., Weinkauf, C., & Conti, P. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000148026.86483.4f · Cited by 56
Self-citation
Cited by
Maternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla Bernardina, B., & Bonassi, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.011 · Cited by 365
Herbert, M. R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328336a01f · Cited by 356
Lv, Y.-T., Zhang, Y., Liu, M., Qiuwaxi, J.-N.-T., Ashwood, P., Cho, S. C., Huan, Y., Ge, R.-C., Chen, X.-W., Wang, Z.-J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-196 · Cited by 174
“Introduction Autism spectrum disorders (ASD) are heterogeneous neurodevelopmental disorders [1].”
BackgroundGhezzo, A., Visconti, P., Abruzzo, P. M., Bolotta, A., Ferreri, C., Gobbi, G., Malisardi, G., Manfredini, S., Marini, M., Nanetti, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066418 · Cited by 164
Metadata
- Authors
- Theoharides, T. C., Kempuraj, D., & Redwood, L.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2009-07-29
- Volume
- 10
- Issue
- 13
- Pages
- 2127-2143
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W1995864156
- Cited by
- 79
- References
- 52
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.